V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240008472 | 240005184 | 1.61 | 90 | Disease modification (D) | 2017-08-25 | 2017-09-21 | Cytarabine Low Dose | N | N | 240012143 | BEVACIZUMAB + CISPLATIN + PACLITAXEL |
| 240008473 | 240005185 | null | 82.7 | Curative (C) | 2014-08-19 | 2014-08-20 | Docetaxel 100mg/m2 (21 day) | 2 | N | 240012171 | BLEOMYCIN + CISPLATIN + MTOMYCIN |
| 240008474 | 240005186 | 1.6 | 54 | Palliative (P) | 2018-04-08 | 2018-04-09 | CAPECITABINE + OXALIPLATIN | N | N | 240012173 | THALIDOMIDE |
| 240008475 | 240005186 | 1.68 | 58.5 | Disease modification (D) | 2016-03-10 | 2016-03-14 | GEMCITABINE | 2 | N | 240012173 | PILOT TRIAL |
| 240008476 | 240005186 | 1.94 | 75 | Palliative (P) | null | 2017-05-18 | Nilotinib | N | N | 240012173 | FCR |
| 240008477 | 240005187 | 1.6 | 64 | Neo-adjuvant (N) | 2013-08-18 | 2013-08-18 | Bevacizumab+Carbo+Gemcitabine | 02 | N | 240012225 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008478 | 240005188 | 1.79 | 61 | Disease modification (D) | 2015-08-21 | 2015-08-21 | CARBOPLATIN + FLUOROURACIL | 02 | N | 240012235 | CYTARABINE |
| 240008479 | 240010863 | null | 70 | null | 2017-06-06 | 2017-06-06 | Oxaliplatin + Modified de Gramont | Y | N | 240012243 | BEVACIZUMAB + CARBO + GEMCITABINE |
| 240008480 | 240010863 | 1.7 | null | Curative (C) | 2012-03-04 | 2012-03-10 | MPV (cycle 1-4) | N | N | 240012243 | CYCLO + RITUXIMAB + VINCRISTINE |
| 240008481 | 240005189 | 1.73 | 50.8 | Curative (C) | 2016-10-06 | 2016-10-06 | FEC 100 | 02 | N | 240012273 | BEVACIZUMAB + CISPLATIN + PACLITAXEL |
| 240008482 | 240005189 | 1.68 | 68.5 | Curative (C) | 2015-03-20 | 2015-03-21 | Docetaxel 75mg/m2 (21 day) | N | N | 240012273 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008483 | 240005190 | null | 56 | Palliative (P) | 2016-07-04 | 2016-08-09 | Gemcitabine + Capecitabine | N | N | 240012308 | CISPLATIN + ETOPOSIDE |
| 240008484 | 240010865 | null | 84 | Palliative (P) | null | 2015-10-05 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | null | 240012317 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008485 | 240013618 | 1.67 | 0 | Palliative (P) | 2017-08-04 | 2017-09-09 | Triple Intrathecal | N | N | 240012322 | METHOTREXATE INTRATHECAL |
| 240008486 | 240005191 | 1.72 | 50 | Curative (C) | 2018-07-10 | 2018-07-10 | BCG Intravesical | 2 | N | 240012325 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 240008487 | 240005192 | 1.5 | 76 | Palliative (P) | 2013-05-03 | 2013-05-07 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 240012344 | TAC |
| 240008488 | 240010866 | 1.55 | 88.5 | Curative (C) | null | 2017-08-27 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 240012387 | CARBOPLATIN + ETOPOSIDE + IFOSFAMIDE + RITUXIMAB |
| 240008489 | 240010866 | 1.5 | 87.5 | Palliative (P) | 2015-07-06 | 2015-07-06 | ABVD | N | N | 240012387 | CAPECITABINE + CISPLATIN |
| 240008490 | 240005193 | 0 | 63.6 | Curative (C) | 2017-09-26 | 2017-10-05 | GemCarbo Days 1+8 | 02 | N | 240012407 | DOCETAXEL + GEMCITABINE |
| 240008491 | 240005193 | null | 68.7 | Disease modification (D) | 2015-11-03 | 2015-11-03 | GEMCARBO | N | N | 240012407 | BEVACIZUMAB |
| 240008492 | 240005194 | null | 77 | Curative (C) | 2013-11-30 | 2013-12-01 | CYCLO + RITUXIMAB + VINCRISTINE | 02 | null | 240012415 | CAPECITABINE + CISPLATIN |
| 240008493 | 240010868 | null | 77.5 | null | null | 2016-07-04 | METHOTREXATE | null | null | 240012421 | CYTARABINE |
| 240008494 | 240005195 | 1.45 | 68 | Palliative (P) | 2014-03-17 | 2014-03-25 | Cytarabine Low Dose | 01 | null | 240012438 | DOXORUBICIN |
| 240008495 | 240005196 | 1.8 | 120.8 | Not known (9) | 2017-02-25 | 2017-02-25 | ECX | N | N | 240012479 | FLAG + IDARUBICIN |
| 240008496 | 240005196 | null | 69.8 | Curative (C) | 2017-07-26 | 2017-08-03 | CYTARABINE + METHOTREXATE + RITUXIMAB + THIOTEPA | N | N | 240012479 | FCR |
| 240008497 | 240005197 | 1.76 | 68 | Curative (C) | null | 2018-11-28 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE | N | N | 240012895 | FCR |
| 240008498 | 240010870 | 1.65 | 36.55 | Neo-adjuvant (N) | null | 2015-11-14 | CYCLOPHOSPHAMIDE + ETOPOSIDE + RITUXIMAB | N | null | 240012938 | AML19 TRIAL |
| 240008499 | 240010870 | 1.75 | 74 | Palliative (P) | 2018-03-09 | 2018-03-16 | AML17 TRIAL | 2 | N | 240012938 | IBRUTINIB |
| 240008500 | 240010870 | 1.76 | 80 | Palliative (P) | 2017-03-30 | 2017-04-21 | DA-EPOCH-R | N | N | 240012938 | R CODOX-M/ R IVAC |
| 240008501 | 240005198 | 1.59 | 99.2 | Curative (C) | 2015-07-24 | 2015-07-24 | BLEOMYCIN + CISPLATIN + MITOMYCIN | 02 | N | 240013261 | CAPECITABINE + OXALIPLATIN |
| 240008502 | 240005198 | 1.8 | 94 | Curative (C) | null | 2016-12-15 | RCEOP | 01 | N | 240013261 | GEFITINIB |
| 240008503 | 240013621 | 1.8 | 95 | Curative (C) | 2017-06-18 | 2017-06-24 | R-EPOCH | N | N | 240013344 | MPV |
| 240008504 | 240013621 | null | 69 | Neo-adjuvant (N) | 2017-07-24 | 2017-07-30 | FLUOROURACIL + MITOMYCIN | 02 | N | 240013344 | CARBOPLATIN + TOPOTECAN |
| 240008505 | 240005199 | 1.52 | 53 | Curative (C) | 2019-05-15 | 2019-05-16 | Bortezomib (weekly) | 02 | N | 240013419 | CYTARABINE + IDARUBICIN |
| 240008506 | 240010872 | 1.54 | 59.5 | Curative (C) | 2018-07-04 | 2018-07-07 | CISPLATIN + ETOPOSIDE | 02 | N | 240013521 | FLUOROURACIL |
| 240008507 | 240013622 | 1.6 | 60 | Curative (C) | 2013-07-09 | 2013-07-12 | CISPLATIN + FLUOROURACIL | 02 | N | 240013529 | RCEOP |
| 240008508 | 240005200 | 1.76 | null | Palliative (P) | null | 2016-11-01 | AML16 DA 3+10 | N | N | 240013597 | CLADRIBINE |
| 240008509 | 240005201 | 1.61 | 55.4 | Not known (9) | 2014-04-27 | 2014-04-27 | ABVD | 2 | N | 240013608 | FEC + DOCETAXEL |
| 240008510 | 240005201 | 1.49 | 58.8 | Curative (C) | 2018-01-21 | 2018-01-22 | CISPLATIN + FLUOROURACIL | 02 | N | 240013608 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008511 | 240005202 | 1.69 | 64 | Palliative (P) | 2018-05-01 | 2018-05-04 | CHOEP - 21 days | 2 | N | 240013846 | CYCLOPHOSPHAMIDE + RITUXIMAB |
| 240008512 | 240005203 | 1.67 | 68 | Palliative (P) | 2014-05-16 | 2014-05-16 | Temozolomide + RT | 02 | N | 240013888 | BEACOPP |
| 240008513 | 240010874 | 1.72 | null | Curative (C) | 2014-01-18 | 2014-02-09 | CLADRIBINE | 02 | N | 240013940 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE |
| 240008514 | 240010874 | null | 113.9 | Palliative (P) | null | 2017-06-15 | RCEOP | N | null | 240013940 | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE |
| 240008515 | 240005204 | 1.68 | 77 | Palliative (P) | 2013-12-08 | 2014-12-22 | CYCLOPHOSPHAMIDE + RITUXIMAB | N | N | 240014054 | TRASTUZUMAB |
| 240008516 | 240005204 | 1.71 | 51 | Palliative (P) | 2013-09-04 | 2013-09-07 | CAPECITABINE + RT | N | N | 240014054 | PMITCEBO-R |
| 240008517 | 240005205 | 1.74 | null | Curative (C) | 2013-09-18 | 2013-09-20 | Cisplatin + Topotecan | 2 | N | 240014187 | PARAGON TRIAL |
| 240008518 | 240005205 | 1.73 | null | Not known (9) | 2017-07-14 | 2017-07-26 | AML 18 TRIAL | N | N | 240014187 | TRIPLE INTRATHECAL |
| 240008519 | 240005205 | 1.8 | 72 | Curative (C) | 2017-09-01 | 2017-10-03 | Bevacizumab 15mg/kg | 02 | N | 240014187 | CYCLOPHOSPHAMIDE + RITUXIMAB + VINCRISTINE |
| 240008520 | 240005206 | 1.74 | 69.9 | Palliative (P) | 2018-10-03 | 2018-10-09 | Cyclophosphamide + Dex + Rituximab | 02 | N | 240014259 | OXALIPLATIN + MDG |
| 240008521 | 240010877 | 1.68 | 58.4 | null | null | 2018-03-09 | ECHELON-2 TRIAL | N | N | 240014317 | BEVACIZUMAB |